Evaluating Biomarkers as Tools for Early Detection and Prognosis of Heart Failure: A Comprehensive Review

There is a high prevalence of heart failure (HF) worldwide, which has significant consequences for healthcare costs, patient death and quality of life. Therefore, there has been much focus on finding and using biomarkers for early diagnosis, prognostication and therapy of HF. This overview of the re...

Full description

Saved in:
Bibliographic Details
Main Authors: Moza A Alzaabi, Amin Abdelsalam, Majid Alhammadi, Hasan Bani Hani, Ali Almheiri, Nadya Al Matrooshi, Khaled Al Zaman
Format: Article
Language:English
Published: Radcliffe Medical Media 2024-06-01
Series:Cardiac Failure Review
Online Access:https://www.cfrjournal.com/articleindex/cfr.2023.24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846122320251322368
author Moza A Alzaabi
Amin Abdelsalam
Majid Alhammadi
Hasan Bani Hani
Ali Almheiri
Nadya Al Matrooshi
Khaled Al Zaman
author_facet Moza A Alzaabi
Amin Abdelsalam
Majid Alhammadi
Hasan Bani Hani
Ali Almheiri
Nadya Al Matrooshi
Khaled Al Zaman
author_sort Moza A Alzaabi
collection DOAJ
description There is a high prevalence of heart failure (HF) worldwide, which has significant consequences for healthcare costs, patient death and quality of life. Therefore, there has been much focus on finding and using biomarkers for early diagnosis, prognostication and therapy of HF. This overview of the research presents a thorough examination of the current state of HF biomarkers and their many uses. Their function in diagnosing HF, gauging its severity and monitoring its response to therapy are all discussed. Particularly promising in HF diagnosis and risk stratification are the cardiac-specific biomarkers, B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide. Markers of oxidative stress, extracellular matrix, renal function, inflammation and cardiac peptides have shown promise in evaluating HF severity and prognosis. MicroRNAs and insulin-like growth factor are two emerging biomarkers that have shown potential in helping with HF diagnosis and prognosis.
format Article
id doaj-art-569ad425721f48c8a4122a3ba4bfe931
institution Kabale University
issn 2057-7540
2057-7559
language English
publishDate 2024-06-01
publisher Radcliffe Medical Media
record_format Article
series Cardiac Failure Review
spelling doaj-art-569ad425721f48c8a4122a3ba4bfe9312024-12-14T16:05:03ZengRadcliffe Medical MediaCardiac Failure Review2057-75402057-75592024-06-011010.15420/cfr.2023.24Evaluating Biomarkers as Tools for Early Detection and Prognosis of Heart Failure: A Comprehensive ReviewMoza A Alzaabi0Amin Abdelsalam1Majid Alhammadi2Hasan Bani Hani3Ali Almheiri4Nadya Al Matrooshi5Khaled Al Zaman6Cardiothoracic Surgery, Heart, Vascular & Thoracic Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab EmiratesDepartment of Cardiology, Al Qassemi Hospital, Sharjah, United Arab EmiratesCollege of Medicine, University of Sharjah, Sharjah, United Arab EmiratesCollege of Medicine, University of Sharjah, Sharjah, United Arab EmiratesCollege of Medicine, University of Sharjah, Sharjah, United Arab EmiratesCardiothoracic Surgery, Heart, Vascular & Thoracic Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab EmiratesCardiothoracic Surgery, Heart, Vascular & Thoracic Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates; College of Medicine, University of Sharjah, Sharjah, United Arab EmiratesThere is a high prevalence of heart failure (HF) worldwide, which has significant consequences for healthcare costs, patient death and quality of life. Therefore, there has been much focus on finding and using biomarkers for early diagnosis, prognostication and therapy of HF. This overview of the research presents a thorough examination of the current state of HF biomarkers and their many uses. Their function in diagnosing HF, gauging its severity and monitoring its response to therapy are all discussed. Particularly promising in HF diagnosis and risk stratification are the cardiac-specific biomarkers, B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide. Markers of oxidative stress, extracellular matrix, renal function, inflammation and cardiac peptides have shown promise in evaluating HF severity and prognosis. MicroRNAs and insulin-like growth factor are two emerging biomarkers that have shown potential in helping with HF diagnosis and prognosis.https://www.cfrjournal.com/articleindex/cfr.2023.24
spellingShingle Moza A Alzaabi
Amin Abdelsalam
Majid Alhammadi
Hasan Bani Hani
Ali Almheiri
Nadya Al Matrooshi
Khaled Al Zaman
Evaluating Biomarkers as Tools for Early Detection and Prognosis of Heart Failure: A Comprehensive Review
Cardiac Failure Review
title Evaluating Biomarkers as Tools for Early Detection and Prognosis of Heart Failure: A Comprehensive Review
title_full Evaluating Biomarkers as Tools for Early Detection and Prognosis of Heart Failure: A Comprehensive Review
title_fullStr Evaluating Biomarkers as Tools for Early Detection and Prognosis of Heart Failure: A Comprehensive Review
title_full_unstemmed Evaluating Biomarkers as Tools for Early Detection and Prognosis of Heart Failure: A Comprehensive Review
title_short Evaluating Biomarkers as Tools for Early Detection and Prognosis of Heart Failure: A Comprehensive Review
title_sort evaluating biomarkers as tools for early detection and prognosis of heart failure a comprehensive review
url https://www.cfrjournal.com/articleindex/cfr.2023.24
work_keys_str_mv AT mozaaalzaabi evaluatingbiomarkersastoolsforearlydetectionandprognosisofheartfailureacomprehensivereview
AT aminabdelsalam evaluatingbiomarkersastoolsforearlydetectionandprognosisofheartfailureacomprehensivereview
AT majidalhammadi evaluatingbiomarkersastoolsforearlydetectionandprognosisofheartfailureacomprehensivereview
AT hasanbanihani evaluatingbiomarkersastoolsforearlydetectionandprognosisofheartfailureacomprehensivereview
AT alialmheiri evaluatingbiomarkersastoolsforearlydetectionandprognosisofheartfailureacomprehensivereview
AT nadyaalmatrooshi evaluatingbiomarkersastoolsforearlydetectionandprognosisofheartfailureacomprehensivereview
AT khaledalzaman evaluatingbiomarkersastoolsforearlydetectionandprognosisofheartfailureacomprehensivereview